[SRNE] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
09-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -126.76%
YoY- -420.65%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 13,511 9,007 6,477 3,913 4,665 902 1,173 50.22%
PBT -167,340 -82,213 -70,654 -74,081 -16,137 -46,113 -10,975 57.40%
Tax -641 -1,919 -383 -1,377 -1,398 -1,164 -17 83.01%
NP -166,615 -77,740 -56,762 -73,864 -14,187 -44,949 -10,958 57.33%
Tax Rate - - - - - - - -
Total Cost 180,126 86,747 63,239 77,777 18,852 45,851 12,131 56.71%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin -1,233.18 -863.11 -876.36 -1,887.66 -304.12 -4,983.26 -934.19 4.73%
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -0.57 -0.36 -0.46 -0.73 -0.20 -0.97 -0.30 11.27%
EPS Diluted -0.57 -0.36 -0.43 -0.73 -0.20 -0.97 -0.30 11.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.